PSILOCYBIN
Clinical trials for PSILOCYBIN explained in plain language.
Never miss a new study
Get alerted when new PSILOCYBIN trials appear
Sign up with your email to follow new studies for PSILOCYBIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Magic mushroom drug tested to shield cancer patients from Chemo's painful side effect
Prevention Not yet recruitingThis study is testing whether psilocybin, the active compound in 'magic mushrooms,' can prevent or reduce the severity of nerve damage caused by chemotherapy. It will involve 83 adults with breast, colorectal, or head & neck cancer who are scheduled to receive specific chemothera…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Mar 30, 2026 14:30 UTC
-
Magic mushroom drug tested as new hope for back pain sufferers
Symptom relief Not yet recruitingThis Yale University study is testing whether a single dose of psilocybin (the active compound in 'magic mushrooms') can help people with chronic low back pain get more benefit from physical therapy. Researchers want to see if the drug helps patients become more aware of their bo…
Matched conditions: PSILOCYBIN
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Scientists scan brains to unlock magic Mushroom's Mind-Altering secrets
Knowledge-focused Not yet recruitingThis study aims to understand how a single dose of psilocybin, the active compound in 'magic mushrooms,' affects the brain, mood, and empathy in healthy adults. Fifty participants will receive either psilocybin or a placebo, and researchers will measure changes using brain scans,…
Matched conditions: PSILOCYBIN
Phase: PHASE1 • Sponsor: Gabriella Gobbi • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC